Cogent Biosciences to Present at Piper Sandler 33rd Annual Virtual Healthcare Conference
CAMBRIDGE, Mass. and BOULDER, Colo., Nov. 22, 2021 /PRNewswire/ -- Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced Andrew Robbins, Chief Executive Officer and President will participate in a fireside chat and one-on-one investor meetings during the Piper Sandler 33rd Annual Healthcare Conference, taking place virtually November 29 – December 2, 2021.
The pre-recorded fireside chat will be available to conference attendees starting at 10:00 a.m. ET today and will remain available through the end of the conference on Thursday, December 2. Access to the recording will be available under the "Events" tab on the investor relations section of the Cogent Biosciences website at: https://investors.cogentbio.com/events.
About Cogent Biosciences, Inc.
View original content to download multimedia:https://www.prnewswire.com/news-releases/cogent-biosciences-to-present-at-piper-sandler-33rd-annual-virtual-healthcare-conference-301429300.html
SOURCE Cogent Biosciences, Inc.
Company Codes: NASDAQ-NMS:COGT
© 2021 PR Newswire. All Rights Reserved.